REGN Regeneron Pharmaceuticals
Nasdaq · SEC CIK 872589 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $12.91M 15 sales by 7 insiders
- Filings on record
- 402 since 2021-07-02, latest 2026-09-03 16:50
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| POON CHRISTINE A | Dir | — | $4.25M |
| McCourt Marion | EVP Commercial | — | $2.00M |
| Zoghbi Huda Y | Dir | — | $1.92M |
| Pitofsky Jason | VP Ctrl | — | $1.87M |
| Bassler Bonnie L | Dir | — | $1.77M |
| Guarini Kathryn | Dir | — | $660.0K |
| RYAN ARTHUR F | Dir | — | $434.7K |
| MURPHY ANDREW J | EVP Research | — | — |
| Fenimore Christopher R. | EVP Fin CFO | — | — |
| Schenkein David P | Dir | — | — |
Transactions 678
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-31 | 2022-03-29+ | REGN | BROWN MICHAEL S | Dir | M - OptEx | $374.12 | +1,930 | 1,490 | New | +$722.1K |
| DM | 2022-03-31 | 2022-03-29+ | REGN | BROWN MICHAEL S | Dir | S - Sale+OE | $699.00 | -1,930 | 1,082 | -64% | -$1.35M |
| DM | 2022-03-30 | 2022-03-28 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $685.26 | -11.8K | 28.9K | -29% | -$8.10M |
| DM | 2022-03-30 | 2022-03-29 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $687.90 | -2,683 | 30.4K | -8% | -$1.85M |
| DM | 2022-03-30 | 2022-03-28 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $426.56 | +14.5K | 30.0K | +94% | +$6.19M |
| D | 2022-03-23 | 2022-03-21 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $691.31 | -312 | 28.7K | -1% | -$215.7K |
| D | 2022-03-23 | 2022-03-21 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $693.00 | -300 | 28.7K | -1% | -$207.9K |
| D | 2022-03-23 | 2022-03-21 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $381.92 | +400 | 29.1K | +1% | +$152.8K |
| D | 2022-03-23 | 2022-03-21 | REGN | Tessier-Lavigne Marc | Dir | M - OptEx | $380.95 | +7,439 | 9,708 | +328% | +$2.83M |
| D | 2022-03-23 | 2022-03-21 | REGN | Tessier-Lavigne Marc | Dir | S - Sale+OE | $690.00 | -7,439 | 2,269 | -77% | -$5.13M |
| D | 2022-03-18 | 2022-03-16 | REGN | Zoghbi Huda Y | Dir | S - Sale+OE | $675.00 | -2,000 | 1,082 | -65% | -$1.35M |
| D | 2022-03-18 | 2022-03-16 | REGN | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +2,000 | 3,082 | +185% | +$783.8K |
| D | 2022-03-18 | 2022-03-17 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $682.50 | -286 | 29.0K | -1.0% | -$195.2K |
| DM | 2022-03-18 | 2022-03-16+ | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $678.95 | -383 | 28.9K | -1% | -$260.0K |
| D | 2022-03-18 | 2022-03-17 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $381.92 | +365 | 29.2K | +1% | +$139.4K |
| DM | 2022-03-18 | 2022-03-16+ | REGN | Tessier-Lavigne Marc | Dir | M - OptEx | $375.77 | +12.2K | 10.1K | New | +$4.58M |
| DM | 2022-03-18 | 2022-03-16+ | REGN | Tessier-Lavigne Marc | Dir | S - Sale+OE | $678.21 | -12.2K | 2,269 | -84% | -$8.27M |
| DI | 2022-03-15 | 2022-01-04 | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -338 | 141.3K | -0.2% | $0 |
| D | 2022-03-15 | 2022-03-14 | REGN | VAGELOS P ROY | Dir | M - OptEx | $179.13 | +75.0K | 393.7K | +24% | +$13.43M |
| D | 2022-03-15 | 2022-03-14 | REGN | VAGELOS P ROY | Dir | F - Tax | $655.29 | -48.1K | 345.6K | -12% | -$31.52M |
| D | 2022-03-03 | 2022-03-01 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-03-03 | 2022-03-01 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $615.39 | -1,000 | 19.6K | -5% | -$615.4K |
| M | 2022-03-03 | 2022-03-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $618.37 | -100 | 22.5K | -0.4% | -$61.8K |
| M | 2022-03-01 | 2022-02-25+ | REGN | SING GEORGE L | Dir | S - Sale | $618.25 | -4,000 | 28.0K | -12% | -$2.47M |
| I | 2022-02-24 | 2022-02-23 | REGN | BROWN MICHAEL S | Dir | S - Sale | $608.68 | -500 | 7,162 | -7% | -$304.3K |
| DM | 2022-02-24 | 2022-02-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $613.99 | -6,781 | 35.8K | -16% | -$4.16M |
| D | 2022-02-24 | 2022-02-22 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $399.66 | +40.0K | 70.6K | +131% | +$15.99M |
| D | 2022-02-24 | 2022-02-22 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $610.56 | -33.2K | 37.4K | -47% | -$20.28M |
| DM | 2022-02-16 | 2022-02-15 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $629.34 | -3,540 | 61.9K | -5% | -$2.23M |
| D | 2022-02-16 | 2022-02-14 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $179.13 | +10.0K | 68.5K | +17% | +$1.79M |
| D | 2022-02-16 | 2022-02-14 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $626.79 | -6,460 | 62.0K | -9% | -$4.05M |
| D | 2022-02-02 | 2022-02-01 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-02-02 | 2022-02-01 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $607.46 | -1,000 | 19.6K | -5% | -$607.5K |
| M | 2022-02-02 | 2022-02-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $607.14 | -100 | 22.6K | -0.4% | -$60.7K |
| D | 2022-01-05 | 2022-01-03 | REGN | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| DM | 2022-01-05 | 2022-01-03 | REGN | RYAN ARTHUR F | Dir | S - Sale | $624.95 | -100 | 22.5K | -0.4% | -$62.5K |
| D | 2022-01-05 | 2022-01-03 | REGN | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +191 | 22.6K | +0.9% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | Tessier-Lavigne Marc | Dir | A - Grant | $0.00 | +191 | 2,269 | +9% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | POON CHRISTINE A | Dir | A - Grant | $0.00 | +191 | 1,872 | +11% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | Bassler Bonnie L | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 20.6K | +5% | +$342.9K |
| D | 2022-01-05 | 2022-01-03 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $625.00 | -1,000 | 19.6K | -5% | -$625.0K |
| D | 2022-01-05 | 2022-01-03 | REGN | COLES N ANTHONY | Dir | A - Grant | $0.00 | +191 | 1,093 | +21% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +191 | 6,082 | +3% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| D | 2022-01-05 | 2022-01-03 | REGN | SING GEORGE L | Dir | A - Grant | $0.00 | +191 | 30.0K | +0.6% | $0 |
| DM | 2021-12-23 | 2021-12-22 | REGN | YANCOPOULOS GEORGE | Pres, Chief Scientific, Dir | M - OptEx | $221.08 | +442.3K | 1.17M | +61% | +$97.78M |
| DM | 2021-12-23 | 2021-12-22 | REGN | YANCOPOULOS GEORGE | Pres, Chief Scientific, Dir | F - Tax | $610.04 | -310.1K | 1.02M | -23% | -$189.17M |
| MI | 2021-12-20 | 2021-12-16 | REGN | VAGELOS P ROY | Dir | I - Discretionary | $634.98 | -126 | 2,202 | -5% | -$80.0K |
| 2021-12-14 | 2021-12-11 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $664.34 | -753 | 53.1K | -1% | -$500.2K | |
| 2021-12-14 | 2021-12-11 | REGN | McCourt Marion | EVP Commercial | F - Tax | $664.34 | -388 | 20.0K | -2% | -$257.8K | |
| 2021-12-14 | 2021-12-13 | REGN | McCourt Marion | EVP Commercial | S - Sale | $653.12 | -344 | 19.6K | -2% | -$224.7K | |
| 2021-12-14 | 2021-12-11 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $664.34 | -697 | 26.1K | -3% | -$463.0K | |
| 2021-12-14 | 2021-12-11 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $664.34 | -697 | 58.5K | -1% | -$463.0K | |
| 2021-12-14 | 2021-12-11 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $664.34 | -270 | 21.1K | -1% | -$179.4K | |
| 2021-12-14 | 2021-12-11 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $664.34 | -697 | 30.6K | -2% | -$463.0K | |
| DM | 2021-12-14 | 2021-12-10+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $664.34 | -2,081 | 29.4K | -7% | -$1.38M |
| D | 2021-12-14 | 2021-12-13 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $662.50 | -116 | 29.3K | -0.4% | -$76.8K |
| D | 2021-12-14 | 2021-12-10 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $555.67 | +1,500 | 31.5K | +5% | +$833.5K |
| D | 2021-12-10 | 2021-12-08 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +4,344 | 31.3K | +16% | $0 |
| D | 2021-12-10 | 2021-12-08 | REGN | Fenimore Christopher R. | SVP Ctrl | A - Grant | $0.00 | +1,859 | 21.4K | +10% | $0 |
| D | 2021-12-10 | 2021-12-09 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $179.13 | +30.0K | 46.5K | +182% | +$5.37M |
| D | 2021-12-10 | 2021-12-09 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $657.11 | -19.8K | 26.7K | -43% | -$12.99M |
| D | 2021-12-10 | 2021-12-08 | REGN | LAROSA JOSEPH J | EVP GC, Secret | A - Grant | $0.00 | +3,338 | 16.5K | +25% | $0 |
| DM | 2021-12-10 | 2021-12-10 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $666.42 | -781 | 30.7K | -2% | -$520.5K |
| D | 2021-12-10 | 2021-12-08 | REGN | Landry Robert E | EVP Fin CFO | A - Grant | $0.00 | +3,971 | 30.0K | +15% | $0 |
| D | 2021-12-10 | 2021-12-09 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $399.66 | +4,250 | 34.2K | +14% | +$1.70M |
| D | 2021-12-10 | 2021-12-09 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $657.11 | -3,469 | 30.7K | -10% | -$2.28M |
| D | 2021-12-10 | 2021-12-08 | REGN | STAHL NEIL | EVP Research, Development | A - Grant | $0.00 | +2,926 | 53.9K | +6% | $0 |
| D | 2021-12-10 | 2021-12-08 | REGN | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +3,338 | 20.4K | +20% | $0 |
| D | 2021-12-10 | 2021-12-09 | REGN | Tessier-Lavigne Marc | Dir | S - Sale+OE | $665.00 | -3,784 | 2,078 | -65% | -$2.52M |
| D | 2021-12-10 | 2021-12-09 | REGN | Tessier-Lavigne Marc | Dir | M - OptEx | $371.40 | +3,784 | 5,862 | +182% | +$1.41M |
| D | 2021-12-10 | 2021-12-08 | REGN | VAGELOS P ROY | Dir | A - Grant | $0.00 | +1,861 | 318.7K | +0.6% | $0 |
| DI | 2021-12-10 | 2021-10-04 | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -347 | 141.6K | -0.2% | $0 |
| DM | 2021-12-10 | 2021-12-10 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $666.27 | -7,122 | 64.1K | -10% | -$4.75M |
| D | 2021-12-10 | 2021-12-09 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $657.11 | -9,378 | 66.3K | -12% | -$6.16M |
| D | 2021-12-10 | 2021-12-09 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $52.03 | +16.5K | 75.7K | +28% | +$858.5K |
| D | 2021-12-10 | 2021-12-08 | REGN | MURPHY ANDREW J | EVP Research | A - Grant | $0.00 | +3,462 | 59.2K | +6% | $0 |
| D | 2021-12-06 | 2021-12-03 | REGN | STAHL NEIL | EVP Research, Development | M - OptEx | $179.13 | +72.5K | 101.3K | +252% | +$12.99M |
| DI | 2021-12-06 | 2021-11-29 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | +4,605 | 4,605 | New | $0 |
| D | 2021-12-06 | 2021-11-29 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | -4,605 | 28.8K | -14% | $0 |
| D | 2021-12-06 | 2021-12-03 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $632.45 | -50.4K | 51.0K | -50% | -$31.85M |
| D | 2021-12-02 | 2021-12-01 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $639.13 | -1,000 | 17.0K | -6% | -$639.1K |
| D | 2021-12-02 | 2021-12-01 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $342.93 | +1,000 | 18.0K | +6% | +$342.9K |
| M | 2021-12-02 | 2021-12-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $637.53 | -100 | 22.6K | -0.4% | -$63.8K |
| 2021-12-02 | 2021-11-16 | REGN | RYAN ARTHUR F | Dir | G - Gift | $0.00 | -500 | 22.6K | -2% | $0 | |
| M | 2021-11-23 | 2021-11-19+ | REGN | SING GEORGE L | Dir | S - Sale | $656.67 | -3,000 | 31.9K | -9% | -$1.97M |
| DM | 2021-11-19 | 2021-11-19 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Dir | M - OptEx | $221.08 | +520.3K | 651.6K | +396% | +$115.03M |
| DM | 2021-11-19 | 2021-11-19 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Dir | F - Tax | $651.96 | -359.1K | 370.3K | -49% | -$234.14M |
| M | 2021-11-18 | 2021-11-16+ | REGN | SING GEORGE L | Dir | S - Sale | $653.76 | -10.0K | 32.9K | -23% | -$6.54M |
| I | 2021-11-18 | 2021-11-16 | REGN | SING GEORGE L | Dir | S - Sale | $650.00 | -750 | 1,000 | -43% | -$487.5K |
| D | 2021-11-18 | 2021-11-17 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $645.08 | -681 | 26.0K | -3% | -$439.3K |
| D | 2021-11-18 | 2021-11-16 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $651.97 | -3,069 | 26.7K | -10% | -$2.00M |
| D | 2021-11-18 | 2021-11-16 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $399.66 | +3,750 | 29.7K | +14% | +$1.50M |
| DM | 2021-11-17 | 2021-11-16 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $647.17 | -7,167 | 61.5K | -10% | -$4.64M |
| D | 2021-11-17 | 2021-11-15 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $641.50 | -9,412 | 62.9K | -13% | -$6.04M |
| D | 2021-11-17 | 2021-11-15 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $52.03 | +16.6K | 72.3K | +30% | +$862.6K |
| D | 2021-11-17 | 2021-08-16 | REGN | MURPHY ANDREW J | EVP Research | G - Gift | $0.00 | -1,645 | 55.7K | -3% | $0 |
| D | 2021-11-17 | 2021-11-15 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $270.43 | +25.0K | 51.9K | +93% | +$6.76M |
| D | 2021-11-17 | 2021-11-15 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $641.50 | -18.2K | 33.7K | -35% | -$11.69M |
Purchase Sale Sale after option exercise All abbreviations